OBALON THERAPEUTICS INC·4

May 17, 7:19 PM ET

VandenBerg Amy 4

4 · OBALON THERAPEUTICS INC · Filed May 17, 2018

Insider Transaction Report

Form 4
Period: 2018-05-15
VandenBerg Amy
VP of Reg. and Clin. Affairs
Transactions
  • Award

    Common Stock (Restricted Stock Award)

    2018-05-15+15,00075,000 total
Holdings
  • Common Stock

    6,650
Footnotes (1)
  • [F1]The Restricted Shares shall vest as to 100% of the Shares underlying the Award on January 2, 2020, subject to the reporting person's provision of service to the Issuer.

Documents

1 file
  • 4
    marketforms-42032.xmlPrimary

    PRIMARY DOCUMENT